table of contents table of contents

A new method for generating high and stable protein expressing cell lines …

Home » Biology Articles » Biotechnology » Efficient and reproducible generation of high-expressing, stable human cell lines without need for antibiotic selection » References

- Efficient and reproducible generation of high-expressing, stable human cell lines without need for antibiotic selection

  1. Martinez-Salas F: Internal ribosome entry site biology and its use in expression vectors.

    Curr Opin Biotechnol 1999, 10:458-464.

  2. Bebbington CR, Renner G, Thomas S, King D, Abrams D, Yarranton GT: High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker.

    Biotechnology 1992, 10:169-175.

  3. Pu H, Cashion LM, Kretschmer PJ, Liu Z: Rapid establishment of high-producing cell lines using dicistronic vectors with glutamine synthetase as the selection marker.

    Mol Biotechnol 1998, 10:17-25. 

  4. Lo KM, Lynch CA, Gillies SD: The use of a wild-type dihydrofolate reductase-encoding cDNA as a dominant selectable marker and induction of expression by methotrexate.

    Gene 1992, 121:365-369.

  5. Urlaub G, Chasin LA: Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity.

    Proc Natl Acad Sci USA 1980, 77:4216-4220.

  6. Mulligan RC, Berg P: Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase.

    Proc Natl Acad Sci USA 1981, 78:2072-2076. 

  7. Tindall KR, Stankowski LF, Machanoff R, Hsie AW: Analyses of mutation in pSV2gpt-transformed CHO cells.

    Mutat 1986, 160:121-131.

  8. Nairn RS, Adair GM, Humphrey RM: DNA-mediated gene transfer in Chinese hamster ovary cells: clonal variation in transfer efficiency.

    Mol Gen Genet 1982, 187:384-390. 

  9. Klessig DF, Grodzicker T, Cleghon V: Construction of human cell lines which contain and express the adenovirus DNA binding protein gene by cotransformation with the HSV-1 tk gene.

    Virus Res 1984, 1:169-188.

  10. Ludwig DL: Mammalian expression cassette engineering for high-level protein production. Components, strategies and options.

    BioProcess International 2006, 4(Sup 3):14-23.

  11. Wurm FM: Production of recombinant protein therapeutics in cultivated mammalian cells.

    Nat Biotechnol 2004, 22:1393-1398.

  12. Richards EJ, Elgin SC: Epigenetic codes for heterochromatin formation and silencing: rounding up the usual suspects.

    Cell 2002, 108:489-500.

  13. Mutskov V, Felsenfeld G: Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9.

    EMBO J 2004, 23:138-149.

  14. Girod PA, Mermod N: Use of scaffold/matrix-attachment regions for protein production. In Gene Transfer and Expression in Mammalian Cells. Edited by: Makrides SC. Amsterdam: Elsevier Science BV; 2003:359-379. 

  15. Fukushige S, Sauer B: Genomic targeting with a positive-selection lox integration vector allows highly reproducible gene expression in mammalian cells.

    Proc Natl Acad Sci USA 1992, 89:7905-7909.

  16. Schlake T, Bode J: Use of mutated FLP recognition target (FRT) sites for the exchange of expression cassettes at defined chromosomal loci.

    Biochemistry 1994, 33:12746-12751. 

  17. Graham FL, Smiley J, Russell WC, Nairn : Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

    J Gen Virol 1977, 36:59-74. 

  18. Cho MS, Yee H, Chan S: Establishment of a human somatic hybrid cell line for recombinant protein production.

    J Biomed Sci 2002, 9:631-638. 

  19. Fallaux FJ, Bout A, van der Velde I, van den Wollenberg DJ, Hehir KM, Keegan J, Auger C, Cramer SJ, van Ormodt H, van der Eb AJ, Valerio D, Hoeben RC: New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competend adenoviruses.

    Hum Gene Ther 1998, 9:1909-1917.

  20. Schiedner G, Hertel S, Kochanek S: Efficient transformation of primary human amniocytes by E1 functions of Ad5: generation of new cell lines for adenoviral vector production.

    Hum Gene Ther 2000, 11:2105-2116.

  21. Schiedner G, Gaitatzis N, Hertel S, Bialek C, Kewes H, Volpers C, Waschuetza G: Human Cell Lines for Production of Biopharmaceuticals.

    Cells and Culture. Proceedings of the 20th ESACT Meeting (Dresden), in press.

  22. Hodges LC, Laine R, Chan SK: Structure of the oligosaccharide chains in human α1-protease inhibitor.

    J Biol Chem 1979, 254:8208-8212. 

  23. Mega T, Lujan E, Yoshida A: Studies on the oligosaccharide chains of human α1-protease inhibitor. II. Structure of oligosaccharides.

    J Biol Chem 1980, 255:4057-4061.

  24. Andus T, Gross V, Tran-Thi TA, Heinrich PC: Interaction of mature, unglycosylated and cell-free synthesized rat alpha 1-proteinase inhibitor with elastase.

    Eur J Biochem 1983, 136:253-257. 

  25. Weber W, Steube K, Gross V, Tran-Thi TA, Decker K, Gerok W, Heinrich PC: Unglycosylated rat alpha 1-proteinase inhibitor has a six-fold shorter plasma half-life than the mature glycoprotein.

    Biochem Biophys Res Commun 1985, 126:630-635.

  26. Guzdek A, Potempa J, Dubin A, Travis J: Comparative properties of human alpha-1-proteinase inhibitor glycosylation variants.

    FEBS Lett 1990, 272:125-127. 

  27. Gross V, Geiger T, Tran-Thi TA, Gauthier F, Heinrich PC: Biosynthesis and secretion of alpha 1-antitrypsin in primary cultures of rat hepatocytes. Characterization of differently glycosylated intracellular and extracellular forms.

    Eur J Biochem 1982, 129:317-323. 

  28. Campbell CT, Yarema KJ: Large-scale approaches for glycobiology.

    Genome Biol 2005, 6:236. 

  29. van den Heuvel SJ, The SI, Klein B, Jochemsen AG, Zentema A, van der Eb AJ: p53 share an antigenic determinant with proteins of 92 and 150 kilodaltons that may be involved in senescene of human cells.

    J Virol 1992, 66:591-595. 

  30. Gallimore PH, Grand RJ, Byrd PJ: Transformation of human embryo retinoblasts with simian virus 40, adenovirus and ras oncogenes.

    Anticancer Res 1986, 6:499-508. 

  31. Hoehn H, Bryant EM, Karp LE, Martin GM: Cultivated cells from diagnostic amniocentesis in second trimester pregnancies. 1. Clonal morphology and growth potential.

    Pediatr Res 1974, 8:756-754.

  32. De Coppi P, Bartsch GJ, Siddiqui MM, Xu T, Santos CC, Perin L, Mostoslavsky G, Serre AC, Snyder Ey, Yoo JJ, Furth ME, Soker S, Atala A: Isolation of amniotic stem cell lines with potential for therapy.

    Nat Biotechnol 2007, 25:100-106.

  33. McDaniel LD, Schultz RA: Elevation of sister chromatid exchange frequency in transformed human fibroblasts following exposure to widely used aminoglycosides.

    Environ Mol Mutagen 1993, 21:67-72.

  34. Rodolosse A, Barbat A, Chantret I, Lacasa M, Brot-Laroche E, Zweibaum A, Rousset M: Selecting agent hygromycin B alters expression of glucose-regulated genes in transfected Caco-2 cells.

    Am J Physiol 1998, 274:G931-938.

  35. Wurm FM, Jordan M: Gene transfer and gene amplification in mammalian cells. In Gene Transfer and Expression in Mammalian Cells. Edited by: Makrides SC. Amsterdam: Elsevier Science BV; 2003:309-335.

  36. Quinlan MP: Expression of antisense E1A in 293 cells results in altered cell morphologies and cessation of proliferation.

    Oncogene 1993, 8:257-265. 

  37. Chen C, Chasin LA: Cointegration of DNA molecules introduced into mammalian cells by electroporation.

    Somat Cell Mol Genet 1998, 24:249-256.

  38. Geisberg JV, Lee WS, Berk AJ, Ricciardi RP: The zinc finger region of the adenovirus E1A transactivating domain complexes with the TATA box binding protein.

    Proc Natl Acad Sci USA 1994, 91:2488-2492.

  39. Lillie JW, Green MR: Transcription activation by the adenovirus E1a protein.

    Nature 1989, 338:39-44. 

  40. Olive DM, Al-Mulla W, Simsek M, Zarban S, Al-Nakib W: The human cytomegalovirus immediate early enhancer-promoter is responsive to activation by the adenovirus-5 13S E1A gene.

    Arch Virol 1990, 112:67-80. 

rating: 3.00 from 2 votes | updated on: 29 Nov 2008 | views: 17232 |

Rate article: